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We report a laboratory-confirmed case of severe acute
respiratory syndrome (SARS) in a pregnant woman.
Although the patient had respiratory failure, a healthy infant
was subsequently delivered, and the mother is now well.
There was no evidence of viral shedding at delivery.
Antibodies to SARS virus were detected in cord blood and
breast milk. 
S
evere acute respiratory syndrome (SARS) is a potential-
ly life-threatening, atypical pneumonia that results from
infection with a novel virus, SARS-associated coronavirus
(SARS-CoV) (1–3). Limited studies and case reports sug-
gest that other viral illnesses during pregnancy are some-
times associated with an increased risk for maternal illness
and death (e.g., influenza) (4) and congenital anomalies
(rubella and varicella) (5,6). No data exist regarding the
effects of previously identified human coronaviruses on
pregnancy. However, porcine reproductive and respiratory
syndrome virus, an animal virus related to coronaviruses, is
commonly associated with early fetal demise in pigs (7). In
contrast, infection with feline infectious peritonitis virus, an
animal coronavirus, results in newborn kittens’ becoming
immune carriers of the virus (8). Data are limited regarding
the effect of SARS-CoV on human pregnancy (9). We
report additional details on the clinical course and out-
comes of a case of laboratory-confirmed SARS-CoV infec-
tion in a pregnant woman (10).
Case Report
A36-year-old, previously healthy, Asian woman (gravi-
da 2, para 1) at 19 weeks’ gestation with a low-lying pla-
centa traveled in late February from the United States to
Hong Kong with her husband and child. Before departing
from the United States, the patient had been complaining
of a mild, intermittent cough without fever for approxi-
mately 10 days. The cough, similar to one she had during
her previous pregnancy, did not impair her ability to func-
tion. While in Hong Kong, between February 19 and
March 2, 2003, she stayed at the same hotel and on the
same floor as a physician from southern China, who is
believed to have been the source of infection for patients
who were the index case-patients in subsequent outbreaks
of SARS in Hong Kong, Singapore, Hanoi, and Toronto,
Canada (11). On February 24, fever, headache, weakness,
anorexia, increasing cough, and shortness of breath devel-
oped in the patient. The next morning, she sought medical
attention and was prescribed chlorpheniramine and aceta-
minophen. Her symptoms worsened, prompting her to see
another physician 2 days later. A fetal ultrasound per-
formed at this time was reportedly normal. Cephalexin was
added to her regimen, but her condition did not improve;
that night, she noted blood-tinged sputum. 
On March 2, the patient returned to the United States
where, acutely short of breath, she was hospitalized with
pneumonia. Her highest temperature on admission was
102.5°F (39.2°C). Although chest auscultation was nor-
mal, chest radiography showed diffuse bilateral lower lobe
infiltrates (Figure, part A). Admission arterial blood gas
analysis showed pH 7.47, PaCO2 31 mm Hg, and PaO2
75 mm Hg on room air. Other pertinent laboratory findings
included a leukocyte count of 3,300/mm3 (normal range
4,500–11,500/mm3) with a differential of 83% polymor-
phonuclear cells, 12% lymphocytes, and 5% monocytes;
platelets of 103,000/mm3 (normal range 150,000–
450,000/mm3); and alanine aminotransferase of 42 U/L
(normal range 10–40 U/L). She was given supplemental
oxygen for hypoxia and intravenous azithromycin and
ampicillin to treat typical and atypical respiratory
pathogens associated with community-acquired pneumo-
nia. A fetal ultrasound performed on March 3 demonstrat-
ed a live intrauterine fetus of approximately 21 weeks
gestational age and complete placenta previa. Despite
antibiotic therapy, over the next 3 days, the patient became
increasingly dyspneic; rales and decreased breath sounds
developed, and she had radiographic evidence of progres-
sive pulmonary infiltrates (Figure, part B). During this
time, ticarcillin-clavulanate was added to her antimicrobial
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possible legionellosis. Because the patient’s diagnosis
remained elusive, tuberculosis was considered, and she
was placed in airborne isolation. Arterial blood gas analy-
sis on March 5 showed: pH 7.48, PaCO2 31 mm Hg, and
PaO2 57 mm Hg on a 100% nonrebreather mask. The
patient was subsequently placed on a mechanical ventila-
tor. When avian (H5N1) influenza was considered in the
differential diagnosis, oseltamivir was added to her thera-
py. During the next several days, she began to improve.
Chest auscultation demonstrated few bibasilar rales, and a
chest radiograph showed interval improvement (Figure,
part C). She was afebrile by March 9 and extubated on
March 12. On March 13, she had a fetal ultrasound that
showed fetal growth consistent with dates and complete
placenta previa. On March 17, she was discharged to
home. Sputum, blood, and urine cultures; smears for acid-
fast bacilli; and tests for Legionella urinary antigen,
influenza nasopharyngeal antigen, and cold agglutinins
were negative. Serum specimens collected 12 and 29 days
after illness onset were tested at the Centers for Disease
Control and Prevention (CDC) and found to be positive for
SARS-CoV antibody. 
Afollow-up ultrasound examination on April 29 during
routine prenatal care showed fetal growth consistent with
dates and persistent complete previa. On May 2 (approxi-
mately 30 weeks’ gestation), the patient was diagnosed
with gestational diabetes after an abnormal oral glucose
tolerance test. Her diabetes was well-controlled by diet
during the remainder of her pregnancy. Because serial
ultrasounds performed on May 28 and June 24 demonstrat-
ed complete placenta previa, she underwent a cesarean
section at 38 weeks’ gestation. A 6-lb, 15-oz (3,145-g)
healthy female infant was delivered without complica-
tions. Apgar scores at 1 and 5 minutes were 9 and 9. Gross
and microscopic inspection of the placenta did not show
major abnormalities. 
After informed consent was obtained, the following
specimens (collected approximately 130 days after illness
onset) were submitted to CDC for coronavirus testing:
serum, whole blood, nasopharyngeal and rectal swab spec-
imens from the mother, postdelivery placenta, cord blood,
amniotic fluid, and breast milk. No viral RNA was detect-
ed in specimens tested by reverse transcriptase–poly-
merase chain reaction. Antibodies to SARS-CoV were
detected in maternal serum, cord blood, and breast milk by
enzyme immunoassay and indirect immunofluorescence
assay (Table). 
Conclusions
On the basis of previous reports from Hong Kong,
SARS-CoV infection can be associated with critical mater-
nal illness, spontaneous abortion, or maternal death (9,12).
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Figure. Chest radiographs of case-patient with severe acute respi-
ratory syndrome (SARS) while pregnant. A, day 6 of illness; B, day
10; C, day 13.
A
B
CWe have described a serious SARS-associated illness that
necessitated mechanical ventilation in a pregnant case-
patient. Her pregnancy was also complicated by placenta
previa and gestational diabetes—two conditions that she
was at increased risk of developing because of advanced
maternal age (13). The infant appeared unaffected by the
mother’s SARS. However, at the time of delivery, clinical
specimens from the infant were not available for SARS-
CoV testing. 
All healthcare workers involved in the delivery and
subsequent care of the infant have remained healthy.
However, serologic testing for SARS-CoV infection was
not performed on these persons. The infant was delivered
by cesarean section with contact, droplet, and airborne pre-
cautions in place (i.e., staff wore fit-tested N95 respirators
and the cesarean section took place in a negative-pressure
operating room). Since SARS-CoV was not detected in
specimens collected at delivery and the patient delivered
months after her illness onset, it is not clear if such precau-
tions were necessary. However, other patients have
demonstrated viral shedding in feces (14,15) and peri-
toneal fluid (16), suggesting that SARS-CoV may be pres-
ent in other body fluids and hence, transmission during
vaginal and cesarean deliveries is plausible. The presence,
in this case, of SARS-CoV antibodies in cord blood and
breast milk raises the issue of whether SARS-CoV infec-
tion during pregnancy results in passive immunity. Serial
serologic testing of newborn clinical specimens and breast
milk may provide a better understanding of the natural his-
tory of the fetal and newborn immune response to SARS-
CoV infection during pregnancy. 
This report, in conjunction with the reports from Hong
Kong (9,12), provides an initial view of the spectrum of ill-
ness and outcomes associated with pregnancy-related
SARS-CoV infection. Avariety of factors might contribute
to this range of outcomes (e.g., timing of SARS-CoV
exposure during pregnancy; use of steroids, ribavirin, or
both; differences in host immune response; the presence of
coexisting conditions). More comprehensive epidemiolog-
ic and clinical summaries about the course of other SARS-
affected pregnancies and long-term follow-up of infants
are needed to fully define the pregnancy-related risks of
this infection. Data on larger numbers of pregnant women
infected with SARS-CoV may help refine infection-
control strategies and provide a sound basis for clinical
guidelines to manage future cases. 
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